The Nurse's Guide to GLP-1 Skin

The mirror changes faster than the body does on a GLP-1. Here is what is actually happening in your skin, and what the evidence supports doing about it.

This article is for educational purposes and does not replace medical advice. Consult a healthcare provider or dermatologist for concerns specific to your skin.


Something shifts in the mirror around month three or four on a GLP-1 medication. The face looks smaller in a way that reads older, not lighter. The cheeks sit lower. The skin feels dry in places it never felt dry before. The glow is gone.

None of this is imagined and none of it is a personal failing. It is the predictable downstream of what a GLP-1 medication does to the body, and it is well documented in the dermatology literature [1] [2] [3].

This guide covers what is actually happening in the face on a GLP-1, why the changes show up on the timeline they do, the patterns readers describe most often, and the framework the evidence supports for responding to them.


What is actually happening in the the face

Rapid weight loss on a GLP-1 pulls fat from the whole body, and the face carries a disproportionate share of the visible cost. The fat compartments under the cheeks, around the eyes, and in the temples give the face its softness and its lift. When those compartments contract quickly, the skin that used to wrap around them has less to wrap around. It settles into the space that opened up underneath it [1] [4].

The dermis itself changes too. Collagen and elastin are the two proteins that give skin its structure and its rebound, and they do not remodel on the same timeline as fat loss. Collagen turns over in months. Elastin barely turns over at all after early adulthood [5] [6]. The mismatch between how fast the scaffolding shrinks and how slowly the skin can adapt to it is where most of what people call Ozempic face comes from (see /why-my-face-looks-different-on-ozempic/).

The rest of the story is nutrition, hydration, and circulation. Appetite suppression is the mechanism the medication uses to work, and it does its job well. Protein intake often drops. Water intake often drops. The micronutrients the skin needs — zinc, iron, essential fatty acids, and the B vitamins — often drop too. All of it shows up on the face before it shows up anywhere else.


Why the changes show up when they do

Facial changes on a GLP-1 do not arrive on day one. The medication has to do enough work for enough time for the volume shift to become visible. For most people that lands somewhere between month three and month six, tracking with the point where meaningful weight loss has accumulated [1] [7].

A recent imaging analysis found that people on GLP-1 medications lose roughly seven percent of midfacial volume for every ten kilograms of total weight loss [7]. That number explains the timeline. It also explains why the face changes faster than the body seems to — the face was carrying a small amount of fat to begin with, so a small absolute loss reads as a large relative change.

The other timeline story is the one nobody warns you about: the first few weeks. Some people notice puffiness on starting a GLP-1, not hollowing. That is not the same phenomenon, and it usually settles once the dose is titrated up and the body adjusts.


The five facial patterns

Different people notice different things first. Five patterns account for most of what shows up in the mirror on a GLP-1.

Change What it looks like Why it happens on a GLP-1
Volume loss Hollowing under the cheekbones, around the temples, and under the eyes. The pattern the term Ozempic face was coined to describe. A subtractive change, not an aging change per se, and it responds to different tools than wrinkles do.
Laxity Skin that has lost its underlying support hangs differently. There is a real difference between skin that has lost the volume it was wrapping around and skin that has been stretched past its own elastic capacity. Topical care can support skin that has lost volume. Skin that has stretched past its elastic limit is a different conversation, and often a different specialty.
Dryness The face looks and feels less hydrated. Partly a systemic story — less fluid coming in, less water available to the skin — and partly a topical one, as the barrier lipids the skin needs to hold water start to run short.
Dullness Skin that used to catch light stops catching it. A vascular and hydration story more than a pigmentation story. When facial microcirculation slows and the outer skin loses water, light scatters instead of reflecting. The face looks matte in a tired way, not a diffused way.
Sensitivity Products that used to sit fine start stinging. The barrier is under multiple simultaneous stresses on a GLP-1 — less nutrition coming in, less water in the skin, active ingredients meeting a thinner and drier surface than they used to meet. Reactivity is one of the ways the skin says so.

One pattern sits outside the main five but earns its own place on the map: acne. Some people break out on a GLP-1, and the reasons are not the same as adolescent acne. Rapid weight loss shifts hormones, and hormonal shifts show up on the face. Dietary changes shift the skin microbiome. The response is different from a teenage breakout, and stripping the routine down to fight it usually backfires.


The framework the evidence supports

The response the dermatology literature converges on is simple to describe and disciplined to execute. Four moves, in this order.

The first move is the barrier. Before any active goes on the face, the barrier has to be intact enough to hold what you put on it. That means a moisturizer that contains ceramides, cholesterol, and fatty acids in a physiological ratio. An occlusive layer at night, when the skin loses water fastest. And a gentle, non-stripping cleanser that does not take the barrier down further than it already is.

The second move is hydration. Humectants pull water into the skin; the barrier above holds it there. Hyaluronic acid and glycerin are the two humectants with the strongest evidence and the widest use, and they work best together — different molecule sizes, different depths of the skin, complementary effects. Applied to damp skin, followed by a barrier-repairing moisturizer, they do most of the hydration work a face on a GLP-1 needs [8] [9].

The third move is collagen support. This is where peptides, retinoids, and antioxidants come in. The dermatology literature converges on a shortlist:

  • Signal peptides and copper peptides — for extracellular matrix stimulation.
  • The retinoid family — with retinal as the middle-strength option for stressed barriers, and bakuchiol as the alternative for people whose barrier will not tolerate a retinoid.
  • Vitamin C — antioxidant and collagen cofactor, usually paired with ferulic acid and tocopherol for stability.
  • Niacinamide — for barrier support and elasticity signaling.
  • Growth factors — which dermatologists frequently name first-line, with important caveats about what the evidence does and does not support [8] [9] [10].

Each of these is a category, not a specific product. What matters is that the routine touches barrier, hydration, and collagen support — not that it uses any one brand or hero ingredient.

The fourth move is nutrition. This is the piece that sits outside the routine and often matters more than the routine. Protein, essential fatty acids, and the micronutrients the skin needs cannot come from a serum. Skin that is not getting the raw materials it needs cannot rebuild itself no matter what goes on top of it.

Sunscreen sits underneath all four moves. Ultraviolet exposure degrades collagen faster than any of the actives above can build it, and the face is in a period of collagen turnover pressure on a GLP-1. A daily broad-spectrum sunscreen is not an optional layer during rapid weight loss.


What the routine looks like in practice

Two people can follow this framework and have very different-looking bathrooms. A barrier-stressed routine is minimal — a gentle cleanser, a humectant, a ceramide moisturizer, sunscreen in the morning, an occlusive at night. A standard routine adds one active per side of the day — antioxidant in the morning, retinoid at night. An advanced routine layers peptides and growth factors in around the actives, and adds targeted treatments for specific concerns.

The mistake most people make on a GLP-1 is stacking too many actives at once because the face looks different and it feels like more products are the answer. The face on a GLP-1 is under more stress than it used to be. More stress calls for less pressure on the barrier, not more.

Two questions come up so often in this space they earn separate consideration. The first is what to do about a retinoid already in the routine when a GLP-1 starts. The short answer is that a well-tolerated retinoid at a low frequency can often continue, but the threshold for pulling it back is lower than it used to be, and the barrier signals matter more than the schedule. The second, for the small subset of readers who notice facial burning or altered sensation during the first months on semaglutide, is a symptom worth mentioning to a prescriber even if the sensation is mild.


When to see someone

Most of what people notice on a GLP-1 responds to the framework above given time and consistency. Some patterns do not, and some patterns are signals that something outside the skin needs attention.

Sudden severe changes. Skin that will not heal from ordinary irritation. Reactivity that does not settle when the routine gets stripped back. Any sign that a nutritional or metabolic issue is contributing — persistent fatigue alongside the skin change, hair thinning outside the normal weight-loss shed, ridges or color changes in the nails. Any of these means a visit to a clinician, not another product.

Procedures — filler, radiofrequency, microneedling, laser, biostimulator injectables — sit outside nursing scope on this site. They are legitimate options for the right person at the right time. Any conversation about them belongs with a board-certified dermatologist or a qualified plastic surgeon who has treated GLP-1 patients before, not with a serum shelf.


Sources & References +
  1. Ozempic face: aesthetic considerations, mechanism, and management, PMC, 2025. pmc.ncbi.nlm.nih.gov/articles/PMC12500303
  2. GLP-1 receptor agonists and facial aging, PMC, 2026. pmc.ncbi.nlm.nih.gov/articles/PMC13385476
  3. GLP-1 receptor agonists: friend or foe for the aesthetic patient, PMC, 2025. pmc.ncbi.nlm.nih.gov/articles/PMC12062882
  4. A closer look at the dermatological profile of GLP-1 agonists, PMC, 2025. pmc.ncbi.nlm.nih.gov/articles/PMC12110338
  5. Dermatologic implications of glucagon-like peptide-1 receptor agonists, Skin Appendage Disorders, 2025. karger.com/sad/article/11/5/416/921780
  6. GLP-1RA and possible skin aging, PMC, 2025. pmc.ncbi.nlm.nih.gov/articles/PMC12370548
  7. Saving face after using GLP-1s for weight loss, Jefferson Health, 2026. jeffersonhealth.org/your-health/living-well/saving-face-after-using-glp1s-for-weight-loss
  8. How GLP-1 drugs affect skin, hair, and nails, American Academy of Dermatology, 2026. aad.org/public/everyday-care/skin-care-secrets/prevent-skin-problems/glp1-drugs-and-side-effects
  9. Multi-ingredient topical treatment significantly improves wrinkles and skin thickness in patients with Ozempic face, Dermatology Times, 2026. dermatologytimes.com/view/multi-ingredient-topical-treatment
  10. What skincare and haircare to use on a GLP-1, tested by editors, Everyday Health, 2026. everydayhealth.com/skin-hair-products/skincare-on-a-glp-1

MEDICAL DISCLAIMER

The information on Skin Logic is written by a registered nurse for educational purposes only. It is not medical advice, does not create a nurse-patient relationship, and is not a substitute for evaluation by your own physician, dermatologist, or licensed clinician. Always consult a qualified healthcare provider or dermatologist for specific skin concerns or medical conditions.